Search results
Yunu Delivers a New Imaging Workflow Paradigm for Investigator-Initiated Trials
Digital Journal· 6 days agoCARY, NC / ACCESSWIRE / May 8, 2024 / Yunu , creator of a first-of-kind clinical trial imaging workflow, reading, and data management platform, is extending the reach of & ...
Owners of home where John O’Keefe was found dead testify in Karen Read trial
WFXT via Yahoo News· 4 days agoJulie Albert doesn’t remember a 12-minute call on 2/1/22 the day Read was arrested. 9:20 a.m. ...of...
Moleculin Biotech Inc (MBRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...
GuruFocus.com via Yahoo Finance· 3 hours agoQ: What are the plans for first-line therapy and how does it compare to second-line therapy...line therapy remains a significant part of their long-term strategy. Q: What updates can we expect ...
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
WKBN 27 Youngstown· 7 days agoASCO 2024 oral presentation of darovasertib neoadjuvant UM Phase 2 investigator-sponsored trial on June 3rd, and targeting neoadjuvant UM update in over ...
Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 8 hours agoI think this quote from a recent paper co-authored by Dr. Simon Best, a laryngologist that...
Uproleselan’s failed Phase III AML trial shakes up GlycoMimetics’ future
Clinical Trials Arena via Yahoo Finance· 6 days agoUproleselan demonstrated encouraging preliminary efficacy and safety as a frontline combination with...
13 Penny Stocks with Insider Buying in 2024
Insider Monkey via Yahoo Finance· 2 days agoIn this article, we will take a detailed look at the 13 Penny Stocks with Insider Buying in 2024. If you want to skip our detailed analysis and see the...
H.C. Wainwright lowers ADC Therapeutics shares target ahead of expected trial updates By...
Investing.com· 7 days agoWainwright to $8.00 from the previous $9.00. The adjustment reflects the analyst's anticipation of...
Earnings call: Intellia Therapeutics reports robust Q1 progress
Investing.com· 5 days agoIntellia Therapeutics (NASDAQ: NASDAQ: NTLA ) has made significant progress in the first quarter of...
ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript May 6, 2024 ADC Therapeutics SA...